<DOC>
	<DOCNO>NCT01660581</DOCNO>
	<brief_summary>The purpose study evaluate efficacy therapy autological CD133+ cell patient angina resistant pharmacological treatment without possibility effective revascularization . Cells isolated patient bone marrow administer directly muscle leave ventricle . The main objective ass treatment ' influence improvement myocardial perfusion function , decrease occurrence symptomatic angina .</brief_summary>
	<brief_title>Intracardiac CD133+ Cells Patients With No-option Resistant Angina</brief_title>
	<detailed_description>Patients Stable angina pectoris ( CCS II-IV ) potentially benefit treatment autological CD133+ cell population , include cell high expression cardiac endothelial differentiation marker . REGENT VSEL Trial include Patients Angina resistant pharmacological treatment without possibility effective revascularization . The main objective study ass treatment influence : - improvement myocardial perfusion - global segmental contractility ( LVEF ) - occurrence symptomatic angina - quality life Regent Vsel prospective , randomize , double blind , placebo-controlled study plan number 60 Patients . Randomization carry accord 1:1 mode . Every Patient undergo bone marrow aspiration . CD133+ cell isolate bone marrow aspirate . Patients randomized experimental group receive isolate cell ( direct leave ventricular muscle administration ) . Patients enrol control group get placebo solution inject muscle .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>1 . Stable angina CCS IIIV despite maximum pharmacotherapy least 2 week since last medication change 2 . Presence â‰¥ 1 myocardial segment ischemia feature Tc99m SPECT 3 . Patients disqualified revascularization procedure Heart Team 4 . Patient age &gt; 18 &lt; 75 year old 5 . Patient must provide write informed consent participation study 1 . Acute coronary syndrome le 6 month prior enrollment 2 . Heart failure NYHA IIIIV 3 . LVEF &lt; 35 % 4 . Presence intracardiac thrombus ( echocardiography confirm ) , massive calcification aortic valve leave ventricular aneurysm 5 . Previous cardioverterdefibrillator cardiac stimulator implantation 6 . Allergy contrast agent 7 . History malignancy 8 . HIV , HBV , HCV infection 9 . Life expectancy le 6 month 10 . Bleeding diathesis 11 . Renal insufficiency ( GFR &lt; 30 mL/min/1.73m2 ) 12 . Pregnancy , lactation , ineffective contraception woman childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>CD133+</keyword>
	<keyword>stem cell</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Stable Angina Pectoris</keyword>
</DOC>